You Searched For "biotech stocks" and got 20 results
Sort By:
2 mins read
A surfer without a degree is worth $16 billion after his biotech company's stock soared 1,100% in a year
Bob Duggan, 80, has gone from baking cookies to building robots, investing in biotech companies, an…
Theron Mohamed
2 mins read
Morgan Stanley just added these 3 safe stocks to their 'buy' list with the market expected to stay choppy
Morgan Stanley suggested PEG, ABBV, and NOC as stocks to buy amid market uncertainty.
Filip De Mott
2 mins read
The stock market will signal a hard landing is coming for the economy if it falls below this key level, Bank of America says
The 5050 level on the S&P 500 corresponds with the index's rising 200-day moving average. As of Fri…
Matthew Fox
1 min read
This overlooked obesity-drug stock has 80% upside, JPMorgan says
JPMorgan said it expects Structure Therapeutics' oral GLP-1 weight loss drug candidate to generate …
Matthew Fox
2 mins read
Concord Biotech lists at 21% premium, beats grey market expectations
Ahmedabad-based pharma company Concord Biotech made its D-street debut at a 21% premium on Friday, …
2 mins read
Concord Biotech IPO allotment – how to check allotment, GMP, listing date and more
Ahmedabad-based Concord Biotech, a biotech company, is expected to announce the allotment status of…
5 mins read
The stock market is getting Ozempic'ed
The collective shedding of hundreds of millions of pounds via GLP-1 drugs is poised reshuffle trill…
Matthew Fox
4 mins read
Yatra Online stock slips below its issue price on listing
Yatra Online’s stock saw a volatile market debut on Thursday. Its price slipped over 8% early on as…
1 min read
Seagen's stock surges almost 11% after a report that Pfizer is in talks to buy the cancer-focused biotech
Pfizer is in early talks to acquire cancer drugmaker Seagen in a potentially multibillion-dollar de…
Zinya Salfiti
3 mins read
Updater Services’ stock slips 5.3% on listing day
Updater Services’ stock made a flat debut on the bourses on Wednesday. It fell very slightly by 0.0…
1 min read
Recursion Pharmaceuticals soars 121% after Nvidia invests $50 million in the biotech for AI drug discovery
Recursion has a library of 3 trillion searchable genes that will serve as the foundation for the co…
Matthew Fox
3 mins read
Sai Silks Kalamandir’s stock gains after debut, ends with 10% listing gains
Sai Silks Kalamandir’s stock debuted on the bourses at a 3.5% premium, in line with grey market exp…
4 mins read
Stellar debut: Plaza Wires stock closes with 48.5% listing gains
Plaza Wires listed on the bourses with a 103.7% premium on Thursday making it one the best listing …
3 mins read
Ratnaveer Precision Engineering stock ends the day with 37% listing gains
The stock of Ratnaveer Precision Engineering made its market debut at ₹128 on the bourses on Monday…
3 mins read
Aeroflex Industries slips on debut day after a stellar listing
The stock of Mumbai-based Aeroflex Industries made its debut on the D-street at a 83% premium on Th…
4 mins read
Samhi Hotels stock rises on debut day, takes listing gains to 15.8%
Samhi Hotels, a branded hotel ownership and asset management company listed at ₹134.50 as compared …
3 mins read
Jupiter Life Line Hospitals stock rises on debut day, listing gains at 46%
The stock of Jupiter Life Line Hospitals made its debut on the stock exchanges with a premium of 31…
2 mins read
Indegene IPO allotment – How to check allotment, GMP, listing date and more
Bengaluru-based Indegene Limited, which provides services to biopharmaceutical, emerging biotech an…
3 mins read
Vishnu Prakash R Punglia stock slips on profit taking after a stellar debut
Vishnu Prakash R Punglia stock made its D-Street debut on Tuesday with 61.2% premium – listing at ₹…
2 mins read
Biotech stocks have hammered hedge funds this year. Here are 5 funds with soured bets on the sector.
The SPDR S&P Biotech ETF is down more than 22% year-to-date, moving almost exactly opposite the S&P…